Is the Bangladeshi version of Cabozantinib cheaper than the original drug?

Cabozantinib (Cabozantinib) is a multi-target tyrosine kinase inhibitor commonly used to treat various malignant tumors such as renal cell carcinoma, hepatocellular carcinoma, and medullary thyroid carcinoma. At present, the drug has not been officially launched in mainland China, so it cannot be purchased directly through domestic hospital pharmacies. For patients in need, they can only rely on formal overseas channels to purchase this drug, especially through cross-border medical platforms or purchasing agents from overseas hospitals. Compared with the situation that has not yet been introduced in China, many versions have been launched abroad, including original drugs and generic drugs.

The overseas original version of cabozantinib is developed and produced by Exelixis. It is currently sold in Europe, the United States, Japan, Hong Kong, Turkey and other markets, and the drug quality standards are high and the efficacy is stable. However, the price is relatively expensive. Depending on the specifications and versions, the price of the original drug is usually between more than 20,000 yuan to more than 50,000 yuan. This is undoubtedly a heavy financial burden for patients who require long-term medication. Therefore, more and more patients are beginning to pay attention to overseas generic versions with the same ingredients and reliable quality.

Currently, in countries such as Laos and Bangladesh, cabozantinib generics have been approved for marketing locally and are produced by GMP-certified pharmaceutical factories. The ingredients of the drug are basically the same as the original drug, and the efficacy has been clinically recognized. These generic versions not only have complete specifications (such as 20mg×90 capsules, 60mg×30 tablets, 80mg The affordable price and good accessibility of generic drugs make them the first choice for patients with limited financial conditions.

To sum up, the price of the Bangladeshi version of cabozantinib is much lower than that of the original drug. Although the drug packaging and sales channels may be different from those of the original drug in Europe and the United States, the active ingredients and therapeutic effects are basically the same. For patients who urgently need the drug but cannot afford the high cost, obtaining generic cabozantinib drugs produced in Bangladesh or Laos through formal channels is a safe and feasible option. It is still recommended to consult a professional doctor before use and ensure that the source of the drug is regular and reliable to ensure the safety and effectiveness of the treatment.

Reference materials:https://www.drugs.com/